The diagnostic utility of TP53 and CDKN2A to distinguish ovarian high-grade serous carcinoma from low-grade serous ovarian tumors - Altman, Alon; Nelson, Gregg S.; Ghatage, Prafull; McIntyre, John B.; Capper, David; Chu, Pamela; Nation, Jill G.; Karnezis, Anthony N.; Han, Guangming; Kalloger, Steve E.; Köbel, Martin (Modern pathology, 2013)
Gesehen am 12.05.2021